Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Certified by Founder
Lodge
Nabla Bio, Inc.
start up
United States
- Allston, MA
- 08/12/2021
- Seed
- $11,000,000
Nabla Bio, in essence, is an antibody design platform.
- Industry Biotechnology Research
- Website https://www.nabla.bio/
- LinkedIn https://www.linkedin.com/company/nabla-bio/about/
Related People
Surge BiswasCo Founder
United States -
Boston, Massachusetts,
I'm a founder and the CEO at Nabla Bio, an antibody design company.
I'm a scientist with 10+ years of experience with using synthetic biology and machine learning to engineer everything from the microbiome to proteins. I completed my PhD from George Church's lab at Harvard.
Google scholar:
https://scholar.google.com/citations?user=rKZUJLUAAAAJ&hl=en&oi=ao
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)